(R)-Di-tert-butyl 2-aminopentanedioate hydrochloride

Catalog No. :
ACSLJI586
CAS No. :
172793-31-6
Molecular Formula :
C13H26ClNO4
Molecular Weight :
295.81

IUPAC Name:di-tert-butyl D-glutamate hydrochloride

(R)-Di-tert-butyl 2-aminopentanedioate hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g97%$150.00Login to see priceIn stockInquiry
500g97%$603.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-Di-tert-butyl 2-aminopentanedioate hydrochloride
IUPAC Namedi-tert-butyl D-glutamate hydrochloride
MDL No.MFCD00237068
Molecular FormulaC13H26ClNO4
Molecular Weight295.81
SMILESO=C(OC(C)(C)C)[C@H](N)CCC(OC(C)(C)C)=O.[H]Cl
InChI KeyLFEYMWCCUAOUKZ-SBSPUUFOSA-N
Synonym172793-31-6 | (R)-Di-tert-butyl 2-aminopentanedioate hydrochloride | H-D-GLU(OTBU)-OTBU HCL | H-D-Glu(OtBu)-OtBu hydrochloride | ditert-butyl (2R)-2-aminopentanedioate;hydrochloride | di-tert-Butyl D-glutamate hydrochloride | H-D-Glu(OtBu)-OtBu.HCl | C13H26ClNO4 | Di-ter
CAS No.172793-31-6
PubChem CID56777380

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACSLJI586 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJZKM039 route compound structure diagram
    ACJZKM0396893-26-1 In Stock
  4. Plus
  5. ACBUNE720 route compound structure diagram
    ACBUNE72010025-64-6
  6. Then
  7. ACSLJI586 route product structure diagram
    ACSLJI586172793-31-6 In Stock
Inquiry

2. ACSLJI586 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSLJI586 route product structure diagram
    ACSLJI586172793-31-6 In Stock
Inquiry

Comments (0)